NVS 241018 115.00C (NVS241018C115000) Stock Options, News & Quotes

US OptionsDetailed Quotes

NVS241018C115000

Watchlist

2.00
-0.02-0.99%

15min DelayTrading Oct 15 11:16 ET

2.25High1.60Low

Intraday

5D
Daily

News

Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women
PR NewswireOct 15 07:32 ET
Looking Into Novartis's Recent Short Interest
BenzingaOct 14 13:00 ET
Novartis AG Rises Monday
Dow JonesOct 14 12:15 ET
Novartis Ends Development of Phase 2 Idiopathic Pulmonary Fibrosis Asset
Seeking AlphaOct 14 11:22 ET
Express News | State Reports Six Human Bird Flu Cases Now Confirmed in California - CDPH
BenzingaOct 11 15:37 ET
Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm
BenzingaOct 10 14:43 ET

Comments

Growth Investor27

2 hours ago

Buyout offer Could be $10+ For Esperion And Could Happen Before 2025

$Esperion Therapeutics (ESPR.US)$ The recent analyst note from Jeff sugest Esperion might sell the entire rights for Bempedoic Acid. Fair valuation on the rights would be above $1.5 billion, based on future milestones $900 million, future royalties & patents, the current formulation patent has exp date Dec 2031. The potential yearly sales in the U.S could reach $4 billion by 2027.
Esperion could also partner in the U.S .
Keep an...

TerenceFung

10 hours ago

Fuiyoh~ first day all green!

Haha... a good start! I never been good with trading, will see how this end

Learn. Trade. Win: Dive into our Global Paper Trading Challenge now!

Moomoo News Global

Sep 19 07:24

Columns Will Rate Cuts Boost the Stock Market? A Global Equity Investment Guide

The Federal Reserve on Wednesday implemented its first rate cut in over four years, reducing the benchmark rate by 50 basis points to a range of 4.75%-5%.
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...

Aggressive 50bp rate cut: How long will the market frenzy last?

Movers and Shakers

Sep 11 07:59

Columns Today's Morning Movers and Top Ratings | GME, MS, DJT and More

Morning Movers
Gapping up
$Williams-Sonoma (WSM.US)$ The home furnishing company saw its shares increase by 2.8% following an upgrade from Jefferies to 'buy' from 'hold.' Jefferies highlighted "hidden gems" in the company's portfolio that could benefit from even a modest recovery in the housing market.
$Viking Therapeutics (VKTX.US)$ Shares of the biotech company soared more than 4.2% as JPMorgan initiated coverage with an 'overweight'...

Election prospects boost DJT's consecutive gains: What's your take?

Movers and Shakers

Sep 3 07:44

Columns Today's Morning Movers and Top Ratings | TSLA, BAC, BA, INTC and More

Morning Movers
Gapping up
$Autodesk (ADSK.US)$ Shares rose by 0.8% following the software group's impressive second-quarter results, which were predominantly above consensus forecasts. The company's recent outlook upgrade also suggests strong business momentum.
$Tesla (TSLA.US)$ Shares increased by 1.2% as the electric vehicle manufacturer reported its best sales month of the year in China for August, driven by strong demand in s...